Background The diagnosis of irritable bowel syndrome (IBS) is challenging because of its
heterogeneity and multifactorial pathophysiology. No reliable biomarkers of IBS have been …

Background Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder for which
no diagnostic tools are currently available. Patients are diagnosed using the Rome IV …

Background Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disease
characterized by intermittent abdominal pain with altered bowel habits. Due to the …

Diagnosing irritable bowel syndrome (IBS) can be a challenge; many clinicians resort to
invasive investigations in order to rule out other diseases and reassure their patients …

OBJECTIVES: The accuracy of available noninvasive biomarkers for diagnosis, stratification,
and prediction of inflammatory bowel disease (IBD) courses is limited. We analyzed volatile …

Volatile organic compounds (VOCs) are produced by the human metabolism, inflammation
and gut microbiota and form the basis of innovative volatomics research. VOCs detected …

Background Evaluation of the metabolomic profile of patients with irritable bowel syndrome
offers an opportunity to identify novel pathophysiological targets and biomarkers that could …

Traditionally, irritable bowel syndrome (IBS) has not been regarded as an organic disease,
and the pathophysiology of IBS is heterogeneous. Currently, the diagnosis of IBS is based …

Background Disappearance of macroscopic mucosal inflammation predicts long-term
outcome in Crohn's disease (CD). It can be assessed by ileocolonoscopy, which is …

Background & Aims Dietary interventions are effective in management of patients with
irritable bowel syndrome (IBS), although responses vary. We investigated whether fecal …